Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof
AssigneeAbbVie Inc.
InventorsJijie Gu, Dominic J. Ambrosi, Susan E. Lappe, Yingchun Li, Jonathan A. Hickson, Deanna L. Haasch, Supriya Gupta, Ravi Chari, Camellia Zamiri, Louie Naumovski, Xianhua Cao
Life of this patent
Estimating the term…
Abstract
Disclosed herein are multivalent and multispecific binding proteins, methods of making the binding proteins, and their uses in the diagnosis, monitoring, inhibition, prevention and/or treatment of cancers, tumors, and/or other angiogenesis-dependent diseases diseases characterized by aberrant DLL4 and/or VEGF expression or activity.
Claims22
1-121. (canceled)
A binding protein comprising first and second polypeptide chains, each independently comprising VD1-(X1)n-VD2-C-(X2)n, wherein
- VD1 is a first variable domain;
- VD2 is a second variable domain;
- C is a constant domain;
- X1 is a linker;
- X2 is an Fc region;
- n is 0 or 1,
- wherein the VD1 domains on the first and second polypeptide chains form a first functional target binding site and the VD2 domains on the first and second polypeptide chains form a second functional target binding site, and wherein the binding protein is capable of binding DLL4 and VEGF, wherein:
- (i) the variable domains that form a functional target binding site for DLL4 comprise:
- three CDRs from SEQ ID NO:
- 39 and three CDRs from SEQ ID NO:
- 40;
- and
- (ii) the variable domains that form a functional target binding site for VEGF comprise:
- three CDRs from SEQ ID NO:
- 41 and three CDRs from SEQ ID NO:
- 42,
- three CDRs from SEQ ID NO:
- 43 and three CDRs from SEQ ID NO:
- 44,
- three CDRs from SEQ ID NO:
- 45 and three CDRs from SEQ ID NO:
- 46,
- three CDRs from SEQ ID NO:
- 47 and three CDRs from SEQ ID NO:
- 48,
- three CDRs from SEQ ID NO:
- 49 and three CDRs from SEQ ID NO:
- 50,
- three CDRs from SEQ ID NO:
- 51 and three CDRs from SEQ ID NO:
- 52, or
- three CDRs from SEQ ID NO:
- 53 and three CDRs from SEQ ID NO:
- 54.
Dependencies are inferred from the claim text.